Loading organizations...
§ Private Profile · Istanbul, Istanbul, Turkey
Medical devices company developing non-invasive, disposable smart contact lenses for continuous IOP monitoring in glaucoma management.
Based in Istanbul, Turkey, GlakoLens is a medical device company that develops non-invasive, disposable smart contact lenses designed to continuously monitor intraocular pressure for glaucoma management and ocular hypertension. Operating as a spin-off from Boğaziçi University, the enterprise utilizes proprietary biosensor technology licensed directly from the institution to address unmet clinical needs within the broader global ophthalmology market. The organization has successfully raised €465,000 in seed funding from lead investor ACT Venture Partners to refine, clinically test, and medically certify its wearable diagnostic equipment for commercial use. Targeting high-risk patient groups, the innovative firm is currently scheduled to present its ongoing clinical progress at the upcoming BIO-Europe Spring conference in Lisbon alongside researchers from Northumbria University. The medical device company was originally founded in 2017 by Professor Günhan Dündar, Doctor Arda Deniz Yalçınkaya, and Doctor Hamdi Torun.
GlakoLens has raised $520K across 1 funding round.
GlakoLens has raised $520K in total across 1 funding round.
GlakoLens has raised $520K across 1 funding round. Most recently, it raised $520K Seed in May 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 25, 2017 | $520K Seed | ACT Venture Partners | — | Announced |
GlakoLens has raised $520K in total across 1 funding round.
GlakoLens's investors include ACT Venture Partners.